Analgesia-based Sedation for Oral Surgery in Patients With Chronic Respiratory Obstructive Disease

J Craniofac Surg. 2023 Jan-Feb;34(1):e70-e74. doi: 10.1097/SCS.0000000000009004. Epub 2022 Sep 14.

Abstract

Chronic obstructive pulmonary disease (COPD) is a risk factor for postoperative cardiovascular and respiratory complications. Thus, intravenous sedation can be a better option than general anesthesia for surgery in patients with severe COPD. Herein, we present 2 cases of analgesia-based sedation in patients with severe COPD who underwent oral surgery. The current study aimed to discuss these cases to provide knowledge about the appropriate sedation management in patients with this disease. In the current cases, the patients received sufficient analgesia and minimum sedation (analgesia-based sedation). Moreover, dexmedetomidine was used for maintaining sedation and fentanyl for analgesic effects. Furthermore, we focused on providing the maximum analgesic effect of local anesthesia. The patients' vital signs were stable. They did not have any psychological or physical complaints, such as anxiety and pain, during the procedure. Then, they were discharged from the hospital without any complications. Thus, analgesia-based sedation can be an alternative option for oral surgery in patients with COPD.

MeSH terms

  • Analgesia* / methods
  • Analgesics, Opioid
  • Dexmedetomidine*
  • Humans
  • Oral Surgical Procedures* / adverse effects
  • Pain
  • Pain, Postoperative / etiology
  • Pulmonary Disease, Chronic Obstructive* / complications

Substances

  • Dexmedetomidine
  • Analgesics, Opioid